Evidence map›Paper›PMID 37934865›Full record

ArticleJCI insight2023

Validation of a murine proteome-wide phage display library for identification of autoantibody specificities.

Elze Rackaityte, Irina Proekt, Haleigh S Miller, Akshaya Ramesh, Jeremy F Brooks, Andrew F Kung, Caleigh Mandel-Brehm, David Yu, Colin R Zamecnik, Rebecca Bair and 9 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Distributed Clonal Deletion Prevents Autoimmune Disease Progression.bioRxiv : the preprint server for biology · 2026
    Article
  4. Gain-of-function mutation inbioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. PhIP-Seq: methods, applications and challenges.Frontiers in bioinformatics · 2024
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 2 countries.

Elze RackaityteDepartment of Biochemistry and Biophysics.
Irina ProektDiabetes Center, School of Medicine.
Haleigh S MillerDepartment of Biochemistry and Biophysics.
Akshaya RameshWeill Institute for Neurosciences, Department of Neurology, School of Medicine.
Jeremy F BrooksDivision of Rheumatology, Rosalind Russell and Ephraim P. Engleman Rheumatology Research Center, Department of Medicine, and.
Andrew F KungDepartment of Biochemistry and Biophysics.
Caleigh Mandel-BrehmDepartment of Biochemistry and Biophysics.
David YuDiabetes Center, School of Medicine.
Colin R ZamecnikWeill Institute for Neurosciences, Department of Neurology, School of Medicine.
Rebecca BairWeill Institute for Neurosciences, Department of Neurology, School of Medicine.
Sara E VazquezDepartment of Biochemistry and Biophysics.
Sara SunshineDepartment of Biochemistry and Biophysics.
Clare L AbramDepartment of Laboratory Medicine, UCSF, San Francisco, California, USA.
Clifford A LowellDepartment of Laboratory Medicine, UCSF, San Francisco, California, USA.
Gabrielle RizzutoHuman Oncology & Pathogenesis Program and Department of Pathology & Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Michael R WilsonWeill Institute for Neurosciences, Department of Neurology, School of Medicine.
Julie ZikhermanDivision of Rheumatology, Rosalind Russell and Ephraim P. Engleman Rheumatology Research Center, Department of Medicine, and.
Mark S AndersonDiabetes Center, School of Medicine.
Joseph L DeRisiDepartment of Biochemistry and Biophysics.
Diabetes Australia · AUNeurosciences Institute · USCenter for Rheumatology · USUniversity of California, San Francisco · USChan Zuckerberg Initiative (United States) · USMemorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
STAT3 variants as a rheostat of immune toleranceP01AI155393 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Mark S Anderson · 2022 to 2026
$10.5M
BMI Bioinformatics Training GrantsT32GM067547 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HERNANDEZ, RYAN D. · 2003 to 2022
$6.6M
Thymic medullary epithelial cell turnover and control of immune toleranceR37AI097457 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Mark S Anderson · 2017 to 2026
$4.0M
Thymic medullary epithelial cell turnover and control of immune toleranceR01AI097457 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ANDERSON, MARK S · 2012 to 2016
$1.9M
Transdisciplinary Research Training to Reduce Disparities in Preterm Birth and Improve Maternal and Neonatal OutcomesT32HD098057 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KUPPERMANN, MIRIAM · 2019 to 2023
$1.4M
Maternal T cell recognition of placental antigenK08AI137209 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI RIZZUTO, GABRIELLE A · 2018 to 2022
$1.0M
Molecular understanding of self immunity in the brainK99NS117800 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MANDEL-BREHM, CALEIGH · 2020 to 2021
$211k
NCI NIH HHS P30 CA008748NIAID NIH HHS K08 AI137209NIAID NIH HHS P01 AI155393NIAID NIH HHS R01 AI097457NIAID NIH HHS R37 AI097457NICHD NIH HHS T32 HD098057NIGMS NIH HHS T32 GM067547NINDS NIH HHS K99 NS117800
6 · The paper itself

Abstract

Autoimmunity is characterized by loss of tolerance to tissue-specific as well as systemic antigens, resulting in complex autoantibody landscapes. Here, we introduce and extensively validate the performance characteristics of a murine proteome-wide library for phage display immunoprecipitation and sequencing (PhIP-seq) in profiling mouse autoantibodies. This library was validated using 7 genetically distinct mouse lines across a spectrum of autoreactivity. Mice deficient in antibody production (Rag2-/- and μMT) were used to model nonspecific peptide enrichments, while cross-reactivity was evaluated using anti-ovalbumin B cell receptor-restricted OB1 mice as a proof of principle. The PhIP-seq approach was then utilized to interrogate 3 distinct autoimmune disease models. First, serum from Lyn-/- IgD+/- mice with lupus-like disease was used to identify nuclear and apoptotic bleb reactivities. Second, serum from nonobese diabetic (NOD) mice, a polygenic model of pancreas-specific autoimmunity, was enriched in peptides derived from both insulin and predicted pancreatic proteins. Lastly, Aire-/- mouse sera were used to identify numerous autoantigens, many of which were also observed in previous studies of humans with autoimmune polyendocrinopathy syndrome type 1 carrying recessive mutations in AIRE. These experiments support the use of murine proteome-wide PhIP-seq for antigenic profiling and autoantibody discovery, which may be employed to study a range of immune perturbations in mouse models of autoimmunity profiling.

Indexed as

AutoantibodiesBacteriophagesAnimalsAutoimmunityHumansMiceMice, Inbred NODPeptidesProteomeAutoantibodiesPeptidesProteomeAdaptive immunityAntigenAutoimmune diseasesAutoimmunityImmunology

Identifiers

PMID37934865
PMCPMC10795829
OpenAlexW4388452269

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.